Citi Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $45

Futu NewsJan 10 19:34 · Ratings

BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference

BridgeBio PharmaJan 8 13:00

BofA Securities Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $45

Futu NewsJan 6 19:31 · Ratings

S&P 500 Futures Drop In Premarket Trading; Sportradar Group, Cytokinetics Lead

Dow JonesDec 27, 2024 20:30

BridgeBio Pharma Is Maintained at Outperform by Evercore ISI Group

Dow JonesDec 24, 2024 02:05 · Ratings

Evercore Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Raises Target Price to $50

Futu NewsDec 23, 2024 22:32 · Ratings